ALEBUND-B(09637.HK) closed 18.75% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector posted broad gains
By the close of trading on Jul 3, 2026, ALEBUND-B(09637.HK) saw a gain of 18.75% in its share price, closing at HKD 30.28. During the session, it reached an intraday high of HKD 31.04 and touched an intraday low of HKD 26.02. The full-day turnover stood at HKD 37.14 million, with the latest market capitalization at HKD 6.88 billion.
On the sector front, the Hang Seng Pharmaceuticals & Biotechnology Sector, to which ALEBUND-B belongs, showed an overall broad gains trend, with 122 stocks advancing and 28 stocks declining.Among the gainers, SINOMAB BIO-B closed higher by 20.37%, FANGZHOU JIANKE closed higher by 19.7%, ALEBUND-B closed higher by 18.75%, BRII-B closed higher by 17.35%, ANTENGENE-B closed higher by 16.76%.Among the decliners, HJ SCIENCE-B closed lower by 13.43%, CLOUDBREAK-B closed lower by 9.79%, AIM VACCINE closed lower by 6.7%, TRANSTHERA-B closed lower by 6.2%, MABPHARM-B closed lower by 5.95%.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- ALEBUND-B(09637.HK) closed 44.47% lower, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
- Alebund-B (09637.HK) Surges 103.54% on Listing Day, Closing at HK$46
- ALEBUND-B(09637.HK): Grey Market Surges 82.74% to HK$41.30
- ALEBUND-B (09637.HK): IPO Subscription Period Closes, Margin Subscription Totals HK$40.611 Billion, Listing Scheduled for 29 June
- Alebund Pharmaceuticals (09637.HK) Launches IPO: Offer Price at HK$22.60 per Share, Listing Expected June 29